Clinical Trial: Pilot Study of Vedic Medicine for Type 2 Diabetes

This study is no longer recruiting patients.

Sponsored by: National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by: National Center for Complementary and Alternative Medicine (NCCAM)

Purpose

The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.

Condition Treatment or Intervention Phase
Diabetes Mellitus, Type 2
 Drug: Vedic Medicine
 Behavior: Vedic Medicine
Phase II

MedlinePlus related topics:  Diabetes

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Further Study Details: 

Expected Total Enrollment:  60

Study start: July 2003;  Study completion: January 2004

Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.

Eligibility

Ages Eligible for Study:  25 Years   -   80 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion criteria:

  • Kaiser Permanente members
  • Newly diagnosed type 2 Diabetes
  • Baseline glycosylated hemoglobin level of 6.0-7.9.

Exclusion criteria:

  • Pregnancy or nursing mother
  • Currently taking warfarin
  • Diagnosis of psychotic disorder or recent hospitalization for depression
  • Unable to comply with or attend treatment sessions

Location Information


Oregon
      Kaiser Permanente Center for Health Research, Portland,  Oregon,  97227,  United States

More Information

Publications

Elder C. Application of the cooperative health care clinic model for the delivery of complementary/ alternative care. The Permanente Journal. Winter 2003; 7(1):55-60.

Elder C. Complementary and Alternative Medicine Symposium: Integrating CAM into clinical practice: The KP northwest story. The Permanente Journal, Fall 2002, 6(4):57-59

Study ID Numbers:  R21 AT001324-01
Record last reviewed:  October 2004
Last Updated:  October 13, 2004
Record first received:  July 30, 2003
ClinicalTrials.gov Identifier:  NCT00065650
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005